• 1
    Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003; 174: 3448.
  • 2
    Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 64983.
  • 3
    Pujol JP, Galera P, Pronost S, Boumediene K, Vivien D, Macro M, et al. Transforming growth factor-β (TGF-β) and articular chondrocytes. Ann Endocrinol 1994; 55: 10920.
  • 4
    Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-β signal transduction. J Cell Sci 2001; 114: 435969.
  • 5
    Bauge C, Legendre F, Leclercq S, Elissalde JM, Pujol JP, Galera P, et al. Interleukin-1β impairment of transforming growth factor β1 signaling by down-regulation of transforming growth factor β receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum 2007; 56: 302032.
  • 6
    Bauge C, Leclercq S, Elissalde JM, Kim SJ, Pujol JP, Galera P, et al. NFκB mediates IL-1β-induced down-regulation of TGFβRII through the modulation of Sp3 expression and its binding on the human TGFβRII core promoter. Submitted for publication.
  • 7
    Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP. Transforming growth factor-β exerts opposite effects from interleukin-1 on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1993; 36: 4450.
  • 8
    Felisaz N, Boumediene K, Ghayor C, Herrouin JF, Bogdanowicz P, Galera P, et al. Stimulating effect of diacerein on TGF-β1 and β2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage 1999; 7: 25567.
  • 9
    Scharstulh A, Diepens R, Lensen J, Vitters E, van Beunigen H, Van der Kraan P, et al. Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGF-β-mediated chondrocyte proliferation and proteoglycan synthesis. Osteoarthritis Cartilage 2003; 11: 77382.
  • 10
    Kaiser M, Haag J, Soder S, Bau B, Aigner T. Bone morphogenetic protein and transforming growth factor β inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1β. Arthritis Rheum 2004; 50: 353540.
  • 11
    Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-κB activation and a reciprocal suppression of TGF-β signal pathway. J Immunol 2006; 176: 5598606.
  • 12
    Grau AM, Datta PK, Zi J, Halder SK, Beauchamp RD. Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells. Cell Signal 2006; 18: 104150.
  • 13
    Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M, et al. A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. J Biol Chem 2004; 279: 392532.
  • 14
    Bitzer M, von Gerdoff G, Liang D, Dominguez-Rosales A, Beg AA, Rojking M, et al. A mechanism of suppression of TGF-β/SMAD signalling by NF-κB/RelA. Genes Dev 2000; 14: 18797.
  • 15
    Nagarajan RP, Chen F, Li W, Vig E, Harrington MA, Nakshatri H, et al. Repression of transforming growth factor-β-mediated transcription by nuclear factor κB. Biochem J 2000; 348: 5916.